Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
Crinetics Pharmaceuticals SG&A Expense (TTM) : 214.37M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 214.37M |
| March 31, 2026 | 206.64M |
| December 31, 2025 | 191.33M |
| September 30, 2025 | 165.81M |
| June 30, 2025 | 139.44M |
| March 31, 2025 | 114.44M |
| December 31, 2024 | 99.74M |
| September 30, 2024 | 88.64M |
| June 30, 2024 | 78.23M |
| March 31, 2024 | 66.73M |
| December 31, 2023 | 58.09M |
| September 30, 2023 | 52.29M |
| June 30, 2023 | 48.73M |
| March 31, 2023 | 45.88M |
| December 31, 2022 | 42.39M |
| September 30, 2022 | 38.48M |
| June 30, 2022 | 32.78M |
| March 31, 2022 | 27.90M |
| December 31, 2021 | 24.52M |
| Date | Value |
|---|---|
| September 30, 2021 | 22.12M |
| June 30, 2021 | 20.65M |
| March 31, 2021 | 19.37M |
| December 31, 2020 | 18.03M |
| September 30, 2020 | 16.46M |
| June 30, 2020 | 15.62M |
| March 31, 2020 | 14.35M |
| December 31, 2019 | 13.52M |
| September 30, 2019 | 12.69M |
| June 30, 2019 | 10.51M |
| March 31, 2019 | 8.567M |
| December 31, 2018 | 6.659M |
| September 30, 2018 | 4.098M |
| June 30, 2018 | 2.857M |
| March 31, 2018 | 1.739M |
| December 31, 2017 | 1.08M |
| September 30, 2017 | 1.08M |
| June 30, 2017 | 0.589M |
| March 31, 2017 | 0.589M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 2.008B |
| Johnson & Johnson | 25.14B |
| Eli Lilly & Co. | 12.24B |
| Bristol Myers Squibb Co. | 7.413B |
| Corcept Therapeutics, Inc. | 556.47M |